# OnCo record lm-108 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lm-108/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lm-108" ;
  schema:name "LM-108"@en ;
  schema:description "LM-108 is an experimental monoclonal antibody from Chia Tai Tianqing Pharmaceutical Nanjing Shunxin Pharmaceutical in phase 3 trials for pancreatic ductal adenocarcinoma and gastric & gastro-oesophageal junction cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/lm-108/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=LM-108>, <https://www.lanovamedicines.com/en> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/gastric/> ;
  onco:companies <https://onco.cc/companies/sino-biopharm/>, <https://onco.cc/companies/lanova-medicines/> ;
  onco:trials <https://onco.cc/trials/nct07362186/>, <https://onco.cc/trials/nct05518045/> .